Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study.

Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study. Neuro Oncol. 2024 Dec 05; 26(12):2316-2327.

View in: PubMed

subject areas

Acrylamides
Adult
Aged
Aged, 80 and over
Aniline Compounds
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Drug Resistance, Neoplasm
ErbB Receptors
Female
Follow-Up Studies
Humans
Indoles
Lung Neoplasms
Male
Meningeal Carcinomatosis
Meningeal Neoplasms
Middle Aged
Mutation
Prognosis
Protein Kinase Inhibitors
Pyrimidines

authors with profiles

Mirjam Boelens